Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon

Pharmacological Research

Volumn 56, Issue 2, 2007, Pages 132-139

  Mulè, Flavia ^a   Amato, Antonella ^a   Baldassano, Sara ^a   Serio, Rosa ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cannabinoids; CB1 receptors; Intestinal motility; NANC contraction; NANC relaxation

Indexed keywords

2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; FATTY ACID AMIDASE INHIBITOR; N (2 CHLOROETHYL) 5,8,11,14 EICOSATETRAENAMIDE; N(G) NITROARGININE METHYL ESTER; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR; NEUROKININ 2 RECEPTOR AGONIST; NEUROKININ 2 RECEPTOR ANTAGONIST; NEUROKININ A [4-10][8 BETA ALANINE]; NOLPITANTIUM; RIMONABANT; SAREDUTANT; TACHYKININ; TETRODOTOXIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CATALYSIS; COLON; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; DRUG SELECTIVITY; ELECTRIC FIELD; ELECTROSTIMULATION; EVOKED MUSCLE RESPONSE; HYDROLYSIS; INTESTINE CONTRACTION; INTESTINE MUSCLE; MEDIATOR RELEASE; MOUSE; NEUROTRANSMISSION; NITRERGIC NERVE; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PRESSURE; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION;

ANIMALS; ARACHIDONIC ACIDS; BENZOXAZINES; CANNABINOIDS; COLON; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ENDOCANNABINOIDS; ENTERIC NERVOUS SYSTEM; EXCITATORY POSTSYNAPTIC POTENTIALS; GASTROINTESTINAL MOTILITY; INDOLES; INHIBITORY POSTSYNAPTIC POTENTIALS; MICE; MICE, INBRED C57BL; MORPHOLINES; NAPHTHALENES; NEUROMUSCULAR JUNCTION; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RECEPTORS, TACHYKININ; SYNAPTIC TRANSMISSION; TACHYKININS;

EID: 34548129626     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2007.04.019     Document Type: Article

References (41)

1. Howlett A.C., Breivogel C.S., Childers S.R., Deadwyler S.A., Hampson R.E., and Porrino L.J. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47 (2004) 345-358
2. Howlett A.C., Barth F., Bonner T.I., Cabral P., Casellas P., Devane W.A., et al. International Union of Pharmacology: XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54 (2002) 161-202
3. Deutsch D.G., Ueda N., and Yamamoto S. The fatty acid amide hydrolase (FAAH). Prostaglandins Leukot Essent Fatty Acids 66 (2002) 201-210
4. Di Marzo V., Bisogno T., and De Petrocellis L. Endocannabinoids: new targets for drug development. Curr Pharm Design 6 (2000) 1361-1380
5. Izzo A.A., Mascolo N., Tonini M., and Capasso F. Modulation of peristalsis by cannabinoid CB(1) ligands in the isolated guinea-pig ileum. Br J Pharmacol 129 (2000) 984-990
6. Pertwee R.G. Cannabinoids and the gastrointestinal tract. Gut 48 (2001) 859-867
7. Coutts A.A., and Izzo A.A. The gastrointestinal pharmacology of cannabinoids: an update. Curr Opin Pharmacol 4 (2004) 572-579
8. Duncan M., Davison J.S., and Sharkey K.A. Endocannabinoids and their receptors in the enteric nervous system. Aliment Pharmacol Ther 22 (2005) 667-683
9. Kulkarni-Narla A., and Brown D.R. Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system. Cell Tissue Res 302 (2000) 73-80
10. Adami M., Frati P., Bertini S., Kulkarni-Narla A., Brown D.R., de Caro G., et al. Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach. Br J Pharmacol 135 (2002) 1598-1606
11. 1 receptor imunoreactivity in the guinea pig and rat myenteric plexus. J Comp Neurol 448 (2002) 410-422
12. Mascolo N., Izzo A.A., Ligresti A., Costagliola A., Pinto L., Cascio M.G., et al. The endocannabinoid system and the molecular basis of paralytic ileus in mice. FASEB J 16 (2002) 973-975
13. Pinto L., Izzo A.A., Cascio M.G., Bisogno T., Hospodar-Scott K., Brown D.R., et al. Endocannabinoids as physiological regulators of colonic propulsion in mice. Gastroenterology 123 (2002) 227-234
14. 1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. Br J Pharmacol 134 (2001) 563-570
15. 1 receptors in the mouse gastroenteric tract. Eur J Pharmacol 459 (2003) 97-105
16. Coutts A.A., and Pertwee R.G. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus. Br J Pharmacol 121 (1997) 1557-1566
17. 1 receptors. Br J Pharmacol 124 (1998) 1363-1368
18. Zygmunt P.M., Petersson J., Andersson D.A., and Chuang E.D. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400 (1999) 452-457
19. 1 cannabinoid receptors. Br J Pharmacol 134 (2001) 161-167
20. Begg M., Dale N., Llaudet E., Molleman A., and Parson M.E. Modulation of the release of endogenous adenosine by cannabinoids in the myenteric plexus-longitudinal muscle preparation of the guinea-pig ileum. Br J Pharmacol 137 (2002) 1298-1304
21. Kojima S., Sugiura T., Waku K., and Kamikawa Y. Contractile response to a cannabimimetic eicosanoid, 2-arachidonoylglycerol, of longitudinal smooth muscle from the guinea-pig distal colon in vitro. Eur J Pharmacol 444 (2002) 203-207
22. Lecci A., Capriati A., Altamura M., and Maggi C.A. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human. Auton Neurosci 126-127 (2006) 232-249
23. Heinemann A., Shahbazian A., and Holzer P. Cannabinoid inhibition of guinea-pig intestinal peristalsis via inhibition of excitatory and activation of inhibitory neural pathways. Neuropharmacology 38 (1999) 1289-1297
24. Storr M., Gaffal E., Saur D., Schusdziarra V., and Allescher H.D. Effects of cannabinoids on neural transmission in rat gastric fundus. Can J Physiol Pharmacol 80 (2002) 67-76
25. 1) receptors coupled to cholinergic motorneurones inhibit neurogenic circular muscle contractility in the human colon. Br J Pharmacol 148 (2006) 191-199
26. Mulè F., Amato A., and Serio R. Effects of cannabinoids on NANC neural transmission in mouse colon. Neurogastroenterol Motil 18 (2006) 781
27. Mulè F., D'Angelo S., Tabacchi G., Amato A., and Serio R. Mechanical activity of small and large intestine in normal and mdx mice: a comparative analysis. Neurogastroenterol Motil 11 (1999) 133-139
28. 2 receptors in the motor activity in mouse colon. Eur J Pharmacol 2007, in press.
29. Calignano A., La Rana G., Makriyannis A., Lin S.Y., Beltramo M., and Pomelli D. Inhibition of intestinal motility by anandamide, an endogenous cannabinoid. Eur J Pharmacol 340 (1999) R7-R8
30. Colombo G., Agabio R., Lobina C., Reali R., and Gessa G.L. Cannabinoid modulation of intestinal propulsion in mice. Eur J Pharmacol 344 (1998) 67-69
31. Izzo A.A., Pinto L., Borrelli F., Capasso R., Mascolo N., and Capasso F. Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil. Br J Pharmacol 129 (2000) 1627-1632
32. Mancinelli R., Fabrizi A., Del Monaco S., Azzena G.B., Vargiu R., Colombo G.C., et al. Inhibition of peristaltic activity by cannabinoids in the isolated distal colon of mouse. Life Sci 69 (2001) 101-111
33. Storr M., Sibaev A., Marsicano G., Lutz B., Schusdziarra V., Timmermans J.-P., et al. Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon. Am J Physiol 286 (2004) G110-G117
34. Pertwee R.G., Fernando S.R., Nash J.E., and Coutts A.A. Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine. Br J Pharmacol 118 (1996) 2199-2205
35. Mathison R., Ho W., Pittman Q.J., Davison J.S., and Sharkey K.A. Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats. Br J Pharmacol 142 (2004) 1247-1254
36. 2-like cannabinoid receptors on peripheral nerve terminals. Eur J Pharmacol 339 (1997) 53-61
37. Croci T., Manara L., Aureggi G., Guagnini F., Rinaldi-Carmona M., Maffrand J.-P., et al. In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum. Br J Pharmacol 125 (1998) 1393-1395
38. Manara L., Croci T., Guagnini F., Rinaldi-Carmona M., Maffrand J.-P., Le Fur G., et al. Functional assessment of neuronal cannabinoid receptors in the muscular layers of human ileum and colon. Digest Liver Dis 34 (2002) 262-269
39. Izzo A.A., Mascolo N., Capasso R., Germanò M.P., De Pasquale R., and Capasso F. Inhibitory effect of cannabinoid agonists on gastric emptying in the rat. N-S Arch Pharmacol 360 (1999) 221-223
40. Clapper J.R., Duranti A., Tontini A., Mor M., Tarzia G., and Piomelli D. The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues. Pharmacol Res 54 (2006) 341-344
41. Capasso R., Matias I., Lutz B., Borrelli F., Capasso F., Morsicano G., et al. Fatty acid amide hydrolase controls mouse intestinal motility in vivo. Gastroenterology 129 (2005) 941-951